The effects of isoproterenol, norepinephrine, dobutamine, exercise, and nitroglycerin on left ventricular diameter, pressure, velocity of shortening, dP/dt, dP/dt/P, arterial pressure, left circumflex coronary blood flow, and coronary vascular resistance were examined in healthy conscious dogs with normal coronary perfusion and in the same animals after moderate global ischemia had been induced by partial occlusion of the left main coronary artery. In the normal nonischemic heart, all interventions improved left ventricular performance, as evidenced by increases in dP/dt/P and velocity at the same or lower left ventricular enddiastolic diameter. Interventions, which in the normal heart caused large increases in heart rate and myocardial contractility, e.g. isoproterenol and exercise, or which decreased coronary perfusion pressure, e.g. nitroglycerin or isoproterenol, elicited paradoxical responses in moderate global ischemia, i.e., left ventricular enddiastolic diameter and pressure rose, and dP/dt/P and velocity fell substantially. On the other hand, norepinephrine, which increased coronary perfusion pressure along with myocardial contractility but did not increase heart rate, improved left ventricular function. Dobutamine, which did not alter heart rate or arterial pressure substantially while improving myocardial contractility, produced an intermediate response between that of norepinephrine and isoproterenol in the presence of moderate global myocardial ischemia. Thus, interventions that increase myocardial O 2 requirements, by increasing heart rate and myocardial contractility without augmenting coronary perfusion pressure, can produce a paradoxical depression […] A B S T R A C T The effects of isoproterenol, norepinephrine, dobutamine, exercise, and nitroglycerin on left ventricular diameter, pressure, velocity of shortening, dP/dt, dP/dt/P, arterial pressure, left circumflex coronary blood flow, and coronary vascular resistance were examined in healthy conscious dogs with normal coronary perfusion and in the same animals after moderate global ischemia had been induced by partial occlusion of the left main coronary artery. In the normal nonischemic heart, all interventions improved left ventricular performance, as evidenced by increases in dP/ dt/P and velocity at the same or lower left ventricular end-diastolic diameter. Interventions, which in the normal heart caused large increases in heart rate and myocardial contractility, e.g. isoproterenol and exercise, or which decreased coronary perfusion pressure, e.g. nitroglycerin or isoproterenol, elicited paradoxical responses in moderate global ischemia, i.e., left ventricular enddiastolic diameter and pressure rose, and dP/dt/P and velocity fell substantially. On the other hand, norepinephrine, which increased coronary perfusion pressure along with myocardial contractility but did not increase heart rate, improved left ventricular function. Dobutamine, which did not alter heart rate or arterial pressure substantially while improving myocardial contractility, produced an intermediate response between that of norepinephrine and isoproterenol in the presence of moderate
INTRODUCTION
Cardioactive sympathomimetic amines, exercise, and nitroglycerin all improve cardiac function, both in the normal heart and in the failing nonischemic heart (1-7).
Despite frequent administration of catecholamines and nitroglycerin to patients with coronary atherosclerosis, their action in the presence of myocardial ischemia is not well established. While these interventions increase coronary blood flow and reduce coronary resistance in the normal heart, their effect might well be different when coronary blood flow is restricted (8) . In fact, it has been recognized clinically that isoproterenol can result in a deterioration of cardiac performance in patients with severe coronary artery disease (9) (10) (11) (12) (13) (14) , and it has been shown experimentally that it can lead to extension of myocardial injury after experimental acute coronary artery occlusion (15, 16) .
The goal of the present investigation was to determine the effects of myocardial ischemia on the response of the left ventricle to several sympathomimetic agents, to exercise, and to nitroglycerin in conscious dogs instrumented for radio telemetry of direct and continuous measurements of left ventricular (LV)1 dimensions, pressures, dP/dt, velocity of fiber shortening, and coronary blood flow. Since the actions of these several stimuli on heart rate and peripheral vascular resistance 'Abbreviations used in this paper: D, left ventricular diameter; LV, left ventricular; P, left ventricular pressure.
The Journal of Clinical Investigation Volume 54 September 1974X563-575may be as important as their direct inotropic effects on altering the function of the ischemic heart, a number of positive inotropic interventions with varying associated chronotropic and pressor effects were compared. Isoproterenol, a pure beta adrenergic agonist which increases contractility in combination with strongly positive chronotropic and hypotensive effects, was compared with: (a) exercise, which increases contractility and heart rate but does not reduce arterial pressure; (b) dobutamine, a beta adrenergic agonist that increases contractility with relatively slight effects on heart rate and arterial pressure2 (5) ; (c) norepinephrine, which increases contractility and arterial pressure but not heart rate (4) ; and (d) nitroglycerin, which causes slight reflex increases in contractility and heart rate secondary to its systemic hypotensive action (7).
METHODS
11 mongrel dogs, weighing between 25 and 35 kg, were anesthetized with i.v. Na pentobarbital, 30 mg/kg. Through a thoracotomy in the fifth left intercostal space, miniature pressure gauges (Konigsberg P22, Konigsberg Instruments, Inc., Pasadena, Calif.) were implanted within the left ventricle through a stab wound in the apex; ultrasonic diameter transducers 8 were implanted on opposing anterior and posterior endocardial surfaces across the transverse diameter of the left ventricle, and Doppler ultrasonic flow transducers were placed around the left circumflex coronary artery; hydraulic occluders were implanted around the left main coronary artery, and heparin-filled catheters were chronically implanted in the thoracic aorta.
The miniature pressure gauges were calibrated in vivo against a calibrated Statham P23 Db strain gauge manometer (Statham Instruments, Inc., Oxnard, Calif.). At autopsy, the position of the ventricular gauges within the ventricular cavity was confirmed. Arterial pressure was sampled with the previously implanted heparin-filled Tygon catheter (Norton Co., Plastics and Synthetics Div., Akron, Ohio) and measured with a Statham P23 Db strain gauge manometer. Left circumflex coronary blood flow was measured with an ultrasonic Doppler flowmeter. This system, which has been described in detail previously, has a reliable zero reference (17, 18) (18) . At autopsy, it was observed that the vessels were firmly adherent to the flow transducers through a fibrous scar which minimized changes in the cross-sectional area of the vessel within the flow trans- ducers.
An improved ultrasonic transit time dimension gauge was used to measure LV diameter (19) (4) (5) (6) (7) 21) . All isolength points were obtained during the first onethird of ejection. For interventions where cardiac size varied greatly, e.g. isoproterenol and nitroglycerin, isolength points could not be found, and peak velocity measurements were reported. In addition, the effects on peak dP/dt and the quotient of dP/dt and developed pressure (LV) isovolumic minus end-diastolic pressure), i.e. dP/dt/ P, were examined. The same level of developed pressure which occurred during isometric contraction, before and after each intervention, was used for this calculation, and dP/dt and P were determined at that level of pressure. This technique for evaluating the myocardial contractile state has also been described in detail previously (4) (5) (6) (7) 22) .
Average and SEM values were calculated. Control and response values were compared in the same animals by using a paired t test (23) . Changes from control with interventions in normal and ischemic states were compared by using the paired t test. (23) .
RESULTS
Partial occlusion of the left main coronary artery produced slight changes from control in resting hemodynamics (Table I ). The increases in heart rate and LV end-diastolic diameter and pressure and the decreases in coronary blood flow, dP/dt, dP/dt/P, and velocity were significant. The hemodynamic values at rest in the presence of the ischemic state remained stable for at least 15 min. Accordingly, it was possible to compare the effects of the various interventions on the same heart in the presence and absence of global ischemia.
To determine the effects of partial left main coronary artery occlusion on left anterior descending coronary blood flow, left anterior descending coronary blood flow was 
Effects of isoproterenol (nine dogs)
Normal response (nonischemic heart). Isoproterenol infusion increased heart rate and reduced mean and late diastolic arterial pressures (Table II) . Mean and late diastolic coronary blood flow rose, while mean and late diastolic coronary vascular resistances fell from 2.57± 0.15 and 1.95±0.12 to 0.83±0.03 and 0.62±0.03 mm Hg/ ml/min, respectively Both LV end-diastolic and endsystolic diameters fell, as did LV end-diastolic pressure (Fig 1) . Peak dP/dt, dP/dt/P, and peak velocity all rose substantially (Table II) .
Partial left main coronary occlusion (moderate global ischemia). As in the normal heart, isoproterenol increased heart rate and reduced arterial pressure, but in contrast to its action in the absence of coronary occlusion, isoproterenol did not alter left circumflex coronary blood flow significantly in the presence of moderate global ischemia (Table II) . After an initial transient improvement in LV function, isoproterenol infusion resulted in a picture of acute cardiac failure (Fig. 1) . LV end-diastolic and end-systolic diameters and LV end-diastolic pressure rose above control levels, while contractility, instead of rising, actually fell drastically (Fig. 2) I Change from control in global ischemia significantly different from normal response, P < 0.01.
flow, LV diameters, end-diastolic pressure, peak dP/dt, dP/dt/P, and velocity were significantly different from the effects observed in the control state (P < 0.01) (Fig. 2) . When the occlusion was relieved, and with continuation of isoproterenol, LV function improved rapidly, as had occurred with isoproterenol in the nonischemic heart (Fig. 1) 23 .5±0.9 mm (P < 0.01). Contractility, as reflected in peak dP/dt, dP/dt/P, and isolength velocity rose to a similar extent as with isoproterenol (Fig. 3) .
Partial left main coronary artery occlusion. As had occurred with isoproterenol, when exercise was carried out in the presence of moderate global ischemia, initial improvement in LV function occurred that was rapidly reversed, and this resulted in a picture of acute cardiac failure (Fig. 4) (Table II) . LV end-diastolic and end-systolic diameters rose, as did LV enddiastolic pressure. Instead of rising, contractility fell, as reflected by decreases in peak dP/dt, dP/dt/P, and isolength velocity (Fig. 3) . The change induced by exercise on LV pressures and diameters and contractility were all significantly different in the presence of moderate global ischemia from those observed in the nonischemic heart. When the occlusion was relieved and the exercise was discontinued, normal function rapidly reappeared.
Effects of dobutamine (six dogs)
Normal response. Dobutamine increased heart rate and mean and late diastolic arterial pressures only slightly (Table II) (Table II) .
Partial left mwin coronary artery occlusion. Dobutamine infusion increased heart rate and mean arterial pressure by similar amounts as in the nonischemic heart (Table II) . However, mean left circumflex coronary blood flow, LV end-diastolic diameter and pressure did not change significantly, LV end-systolic diameter fell only slightly, while contractility rose slightly but not significantly (Fig. 5) . Thus, in the presence of moderate global ischemia, dobutamine produced little change in myocardial contractility, a response which differed significantly (P < 0.01) from that which occurred with the same dose of the drug in the nonischemic heart. In three dogs when more severe global ischemia was induced, dobutamine depressed LV function, as had occurred with isoproterenol and exercise in moderate ischemia. However, with moderate global ischemia, dobutamine clearly was not as deleterious as isoproterenol. (Fig. 7) .
Partial left main coronary occlusion. As in the nonischemic heart, norepinephrine infusion reduced heart rate and increased coronary blood flow significantly.
LV end-diastolic diameter rose, as did LV end-diastolic pressure, while LV end-systolic diameter, instead of falling, remained constant. Contractility increased substantially (P < 0.01) and only slightly less than in the normal heart (Fig. 7) .
Effects of nitroglycerin (nine dogs)
Normtal, response. Nitroglycerin infusion increased heart rate slightly and decreased mean and late diastolic arterial pressures (Table IT) . Mean (Fig. 8) .
Heart rate rose to a greater extent than occurred normally, while mean arterial pressure fell. Coronary blood flow instead of rising, as in the nonischemic heart, fell significantly. LV end-diastolic diameter and pressure, instead of falling as in the nonischemic heart, rose, as did LV end-systolic diameter (Table II) . Contractility, instead of rising, fell substantially (Fig. 8) . The changes in LV diameters and contractility were all significantly different (P < 0.01) from those occurring in the normal heart.
Paradoxical Effects of Inotropic Agents in Myocardial Ischemia When arterial pressure was maintained at control levels with inflation of the intra-aortic balloon, the deterioration in LV function was prevented. Coronary blood flow, LV end-diastolic and systolic diameters, dP/dt, dP/dt/P, and velocity all remained unchanged from the levels achieved by moderate global ischemia alone.
DISCUSSION
Isoproterenol causes striking improvement in normal cardiac performance through its positive chronotropic, inotropic, and peripheral vasodilating actions mediated by stimulation of beta adrenergic receptors. This salutary effect, which has been observed consistently in the normal circulation (1-3) , has resulted in the use of this agent in a variety of clinical conditions in which myocardial function and/or cardiac output are depressed (24, 25) . However, it has been noted that isoproterenol does not always improve cardiac function in patients with severe coronary artery disease (9-11) and can result in excess lactate formation (12) (13) (14) and extension of myocardial injury and necrosis in experimental animals after coronary artery occlusion (15, 16) . In the present study, isoproterenol exerted differing actions in the normal and ischemic heart. It augmented myo- cardial contractility and heart rate and reduced cardiac size in the normal heart, but it produced a paradoxical response in the presence of moderate global ischemia induced by constriction of the left main coronary artery. In the latter condition, before isoproterenol infusion, it may be presumed that the central obstruction to coronary blood flow was sufficiently severe to result in maximal dilatation of peripheral vessels, but not severe enough to depress LV function seriously. With this degree of global LV ischemia, isoproterenol produced only transient improvement of LV function, followed almost immediately by the development of acute cardiac failure; end-diastolic cardiac size rose and contractility, reflected by measurements of peak dP/dt, dP/dt/P, velocity, and the extent of myocardial fiber shortening per stroke, all diminished drastically. It is postulated that in the presence of the central obstruction to coronary blood flow, the reduction in coronary blood flow, the reduction in coronary perfusion pressure caused by the systemic vasodilating effect of the drug, occurring in combination with elevated myocardial oxygen demands (26) (Fig. 6 ). This should not be interpreted to indicate that dobutamine can be administered with impunity in the presence of diffuse myocardial ischemia, since with more severe restriction of coronary blood flow or a greater dose of dobutamine, a paradoxical negative inotropic response was elicited. However, these results suggest that for an equi-inotropic effect, the likelihood of developing or intensifying ischemia is much less with dobutamine than with isoproterenol, since dobutamine can exert a similar positive inotropic action with less of isoproterenol's undesirable side effects, i.e., hypotension and tachycardia.
The results of the experiments with norepinephrine further corroborated our hypothesis. While augmenting myocardial contractility, norepinephrine raises arterial pressure through a powerful alpha adrenergic stimulating action and induces bradycardia through baroreceptor reflexes. Accordingly, it followed that norepinephrine's response was not altered profoundly by the partial occlusion of the left main coronary artery (Fig. 7) . The increase in myocardial contractility that occurred was probably made possible by the increase in coronary flow that accompanied the increase in coronary perfusion pressure. Similar conclusions were reached by Mueller, Ayers, Gregory, Giannelli, and Grace, who reported beneficial results with norepinephrine in patients with myocardial ischemia, while noting that isoproterenol increased lactate production (14) . These results should not be interpreted to mean that norepinephrine is clearly the best therapeutic agent to use in patients with depressed myocardial function due to diffuse myocardial ischemia, since the drug produces alpha adrenergic vasoconstriction in the coronary (4) as well as other peripheral beds (28) through stimulation of alpha adrenergic receptors, and it frequently produces arrhythmias as well.
In conclusion, in the presence of moderate global myocardial ischemia produced by obstruction of the left main coronary artery when coronary blood flow cannot increase, positive inotropic and chronotropic stimuli, by increasing myocardial oxygen demands, unfavorably influence the balance between oxygen supply and demand, thereby intensifying ischemia and resulting in a paradoxical deterioration of cardiac function. Hypotension, which diminishes coronary perfusion pressure and consequently coronary blood flow, is also detrimental in the presence of global myocardial ischemia. Thus, isoproterenol's strongly positive inotropic and chronotropic effects, in combination with its peripheral vasodilating action which reduces coronary perfusion pressure, makes this agent potentially hazardous in the presence of global ischemia, a condition which may occur in patients with diffuse multivessel coronary artery disease. The potent positive inotropic and chronotropic effects induced by exercise and the hypotensive action of nitroglycerin also elicit paradoxical responses which result in deterioration of ventricular function. The administration of a drug, such as dobutamine which increases myocardial contractility in the normal heart without affecting arterial pressure or heart rate substantially, has little effect on LV function in the presence of moderate global ischemia but can be deleterious in the presence of severe global ischemia. Norepinephrine, on the other hand, which increases coronary perfusion pressure along with contractility, improves cardiac performance in the presence of moderate global ischemia as well as in the nonischemic heart.
It is always difficult to extrapolate from the results of a study in an experimental animal model of myocardial ischemia to the patient with severe diffuse coronary artery disease. Nevertheless, these results suggest that in the presence of global ischemia, beta adrenergic-stimulating drugs may either be relatively ineffective in improving myocardial contractility, or actually may be deleterious.
Tachycardia and hypotension also impair cardiac performance, findings which further demonstrate the potential hazards of using isoproterenol, as well as the undesirability of the hypotensive effect of nitroglycerin in the presence of global myocardial ischemia. The high oxygen cost of tachycardia was an important factor in determining the difference in response of the ischemic heart to isoproterenol and exercise, which induced tachycardia on the one hand. and to dobutamine and noreiinephrine, on the other hand, where little or no tachycardia occurred. Norepinephrine, by increasing arterial pressure and coronary blood flow, improves cardiac peformance, which suggests that in the presence of acute global myocardial ischemia, the major effort should be directed towards increasing coronary flow through stenosed coronary vessels by elevating systemic pressure, rather than simply towards improving the myocardial contractile state, which cannot occur without an increase in coronary blood flow.
